Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Microprotein Functions in Messenger RNA Removal Complex

By LabMedica International staff writers
Posted on 15 Dec 2016
A novel "microprotein" has been identified and shown to fulfill a cellular maintenance function by prepping nonessential messenger RNA (mRNA) for destruction and removal from the cytoplasm.

MicroProteins are short single-domain proteins that possess the ability to interfere with larger multi-domain proteins. More...
These protein species can be identified in plants and animals where they evolved from large proteins by successive domain-loss. In previous studies proteomic detection of non-annotated microproteins indicated the translation of hundreds of small open reading frames (smORFs) in human cells, but whether these microproteins had any function was unknown.

Investigators at Yale University (New Haven, CT, USA) located a clutch of microproteins by extracting the large proteins from myeloid leukemia cells and then using liquid chromatography-mass spectroscopy proteomics to determine the amino acid sequences of all remaining small proteins.

They reported in the December 5, 2016, online edition of the journal Nature Chemical Biology that they had identified a 7000 Dalton human microprotein that interacted with mRNA decapping proteins, which remove the 5′ cap from mRNAs to promote 5′-to-3′ decay. Decapping proteins participate in mRNA turnover and nonsense-mediated decay (NMD). The investigators called their novel microprotein "non-annotated P-body dissociating polypeptide" or NoBody.

The investigators found that NoBody localized to mRNA-decay-associated RNA-protein granules called P-bodies. However, the amount of NoBody was not dependent of the number of cellular P-body elements. These results implicated NoBody as a novel component of the mRNA decapping complex and demonstrated the potential functionality of a newly discovered microprotein.

"The broadest significance of this work is that even in a well-studied biological process, a microprotein has been right there under our noses, undetected, all this time," said senior author Dr. Sarah Slavoff, assistant professor of chemistry, molecular biophysics, and biochemistry at Yale University.

Related Links:
Yale University


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Collection and Transport System
PurSafe Plus®
New
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
New
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The study highlights the potential of cCAFs as a biomarker for early diagnosis and prognosis (H J Woo et al., Analytical Chemistry (2025). DOI: 10.1021/acs.analchem.5c02154)

Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy

Accurate cancer diagnosis remains a challenge, as liquid biopsy techniques often fail to capture the complexity of tumor biology. Traditional systems for isolating circulating tumor cells (CTCs) vary in... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.